Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 201–300 of 999
The obstetric management of sickle cell disease
Howard, J., & Oteng‐Ntim, E. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.10.001 · Cited by 108
Longitudinal Decline in Lung Volume in a Population of Children with Sickle Cell Disease
MacLean, J. E., Atenafu, E. G., Kirby-Allen, M. A., MacLusky, I., Stephens, D., Grasemann, H., & Subbarao, P. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1219oc · Cited by 105
Pathophysiologically based drug treatment of sickle cell disease
Steinberg, M. H. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.007 · Cited by 119
Modifier genes and sickle cell anemia
Steinberg, M. H., & Adewoye, A. H. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219656.50291.73 · Cited by 101
Cerebrovascular disease associated with sickle cell pulmonary hypertension
Kato, G. J., Hsieh, M., Machado, R., Taylor, J., Little, J., Butman, J. A., Lehky, T., Tisdale, J., & Gladwin, M. T. (2006) · American Journal of Hematology · doi:10.1002/ajh.20642 · Cited by 100
Self-citationJohnson, M. C., Kirkham, F. J., Redline, S., Rosen, C. L., Yan, Y., Roberts, I., Gruenwald, J., Marek, J., & DeBaun, M. R. (2010) · Blood · doi:10.1182/blood-2009-06-227447 · Cited by 100
Pulmonary Hypertension in β‐Thalassemia
Aessopos, A., & Farmakis, D. T. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.041 · Cited by 100
Iron, Inflammation, and Early Death in Adults With Sickle Cell Disease
van Beers, E. J., Yang, Y., Raghavachari, N., Tian, X., Allen, D. T., Nichols, J. S., Mendelsohn, L., Nekhai, S., Gordeuk, V. R., Taylor, J. G., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304577 · Cited by 100
Self-citationSickle cell disease: Clinical presentation and management of a global health challenge
Houwing, M. E., de Pagter, P. J., van Beers, E. J., Biemond, B. J., Rettenbacher, E., Rijneveld, A. W., Schols, E. M., Philipsen, J. N. J., Tamminga, R. Y. J., van Draat, K. F., et al. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.05.004 · Cited by 122
Pulmonary Hypertension in Children and Adolescents with Sickle Cell Disease
Onyekwere, O. C., Campbell, A., Teshome, M., Onyeagoro, S., Sylvan, C., Akintilo, A., Hutchinson, S. K., Ensing, G. J., Gaskin, P. R. A., Kato, G. J., et al. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9018-x · Cited by 103
Self-citationCoghlan, G., Corris, P. A., Gaine, S., Gatzoulis, M. Α., Gibbs, J. S. R., Haworth, S. G., Kiely, D. G., Peacock, A. J., Pepke‐Żaba, J., Elliot, C. A., et al. (2008) · Cited by 99
Krishnamurti, L., Neuberg, D. S., Sullivan, K. M., Kamani, N. R., Abraham, A., Campigotto, F., Zhang, W., Dahdoul, T., Castro, L. D., Parikh, S. H., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25401 · Cited by 106
Schaer, D. J., & Buehler, P. W. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013433 · Cited by 96
Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline
Oteng‐Ntim, E., Pavord, S. R., Howard, R., Robinson, S. E., Oakley, L., Mackillop, L. H., Pancham, S., & Howard, J. (2021) · British Journal of Haematology · doi:10.1111/bjh.17671 · Cited by 108
Sickle‐cell disease and the heart: review of the current literature
Voskaridou, E., Christoulas, D., & Terpos, E. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09143.x · Cited by 132
Kato, G. J., Wang, Z., Machado, R. F., Blackwelder, W. C., Taylor, J. G., & Hazen, S. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07658.x · Cited by 100
Self-citationComputation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias
Jeffers, A. B., Gladwin, M. T., & Kim‐Shapiro, D. B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.017 · Cited by 100
Self-citationSickle Cell Disease in Children
Meier, E. R., & Miller, J. L. (2012) · Drugs · doi:10.2165/11632890-000000000-00000 · Cited by 117
Zorca, S. M., Freeman, L. A., Hildesheim, M. E., Allen, D. T., Remaley, A. T., Taylor, J. G., & Kato, G. J. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08109.x · Cited by 107
Yu, B., Shahid, M., Egorina, E. M., Sovershaev, M. A., Raher, M. J., Lei, C., Wu, M. X., Bloch, K. D., & Zapol, W. M. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181cd7838 · Cited by 93
Ilesanmi, O. O. (2010) · Hematology Reports · doi:10.4081/hr.2010.e2 · Cited by 108
Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1
Bauer, P. M., Bauer, E. M., Rogers, N. M., Yao, M., Feijoo‐Cuaresma, M., Pilewski, J. M., Champion, H. C., Zuckerbraun, B. S., Calzada, M. J., & Isenberg, J. S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr356 · Cited by 91
Pulmonary Hypertension Associated With Hemoglobinopathies: Prevalent But Overlooked
Farmakis, D. T., & Aessopos, A. (2011) · Circulation · doi:10.1161/circulationaha.110.988089 · Cited by 93
Schein, A. J., Enriquez, C. M., Coates, T. D., & Wood, J. C. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21490 · Cited by 93
Acute chest syndrome: sickle cell disease
Paul, R. N., Castro, O. L., Aggarwal, A., & Oneal, P. A. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01647.x · Cited by 103
Self-citationHaptoglobin Therapeutics and Compartmentalization of Cell-Free Hemoglobin Toxicity
Buehler, P. W., Humar, R., & Schaer, D. J. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.02.004 · Cited by 95
Hebbel, R. P., Vercellotti, G. M., & Nath, K. A. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x10909040271 · Cited by 102
Adisa, O. A., Hu, Y., Ghosh, S., Aryee, D., Osunkwo, I., & Ofori‐Acquah, S. F. (2013) · British Journal of Haematology · doi:10.1111/bjh.12445 · Cited by 88
Schaer, D. J., Alayash, A. I., & Buehler, P. W. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1576 · Cited by 89
Epidemiology of Pulmonary Arterial Hypertension
Taichman, D. B., & Mandel, J. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.010 · Cited by 97
Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions
Shenoy, S. S. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713483063 · Cited by 89
Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era
Morris, A., Gingo, M. R., George, M. P., Lucht, L. A., Kessinger, C. J., Singh, V. K., Hillenbrand, M. E., Busch, M. A., McMahon, D. K., Norris, K. A., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32835099ae · Cited by 85
Self-citationAsthma management: Reinventing the wheel in sickle cell disease
Morris, C. R. (2009) · American Journal of Hematology · doi:10.1002/ajh.21359 · Cited by 87
Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia
Minniti, C. P., Delaney, K., Gorbach, A. M., Xu, D., Lee, C. R., Malik, N., Koroulakis, A. I., Antalek, M. D., Maivelett, J., Peters-Lawrence, M. H., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23571 · Cited by 94
Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy
Kato, G. J. (2008) · JAMA · doi:10.1001/jama.2008.598 · Cited by 85
Quinn, C. T., & Ahmad, N. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05738.x · Cited by 85
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension
Sundaram, N., Tailor, A., Mendelsohn, L., Wansapura, J., Wang, X., Higashimoto, T., Pauciulo, M. W., Gottliebson, W., Kalra, V. K., Nichols, W. C., et al. (2010) · Blood · doi:10.1182/blood-2009-09-244830 · Cited by 86
Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Sleiman, J., Tarhini, A., Bou‐Fakhredin, R., Saliba, A. N., Cappellini, M. D., & Taher, A. T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010182 · Cited by 96
Gordeuk, V. R., Minniti, C. P., Nouraie, M., Campbell, A. D., Rana, S. R., Luchtman-Jones, L., Sable, C., Dham, N., Ensing, G., Prchal, J. T., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.030767 · Cited by 84
Self-citationPrevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study
Moreira, E. M., Gall, H. J., Leening, M. J. G., Lahousse, L., Loth, D. W., Krijthe, B. P., Jong, J. C. K., Brusselle, G., Albert Hofman, D., Stricker, B. H. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130072 · Cited by 88
Determinants of severity in sickle cell disease
Rees, D. C., Brousse, V. A. M., & Brewin, J. N. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100983 · Cited by 108
Glomerular Lesions in Patients With Sickle Cell Disease
Maigné, G., Ferlicot, S., Galactéros, F., Belenfant, X., Ulinski, T., Niaudet, P., Ronco, P. M., Godeau, B., Dürrbach, A., Sahali, S., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181ca59b6 · Cited by 88
Sickle cell disease: a natural model of acute and chronic pain
Brandow, A. M., Zappia, K. J., & Stucky, C. L. (2017) · Pain · doi:10.1097/j.pain.0000000000000824 · Cited by 92
Patel, N. N., Gonsalves, C. S., Malik, P., & Kalra, V. K. (2008) · Blood · doi:10.1182/blood-2007-12-130567 · Cited by 82
Minniti, C. P., Machado, R. F., Coles, W. A., Sachdev, V., Gladwin, M. T., & Kato, G. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07906.x · Cited by 81
Self-citationPulmonary Hypertension in Sickle Cell Disease: Mechanisms, Diagnosis, and Management
Castro, O. L., & Gladwin, M. T. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.07.007 · Cited by 87
Self-citationSickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology
Bakeer, N., James, J., Roy, S., Wansapura, J., Shanmukhappa, S. K., Lorenz, J. N., Osinska, H., Backer, K., Huby, A.-C., Shrestha, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600311113 · Cited by 79
Yuditskaya, S., Tumblin, A., Hoehn, G. T., Wang, G., Drake, S. K., Xu, X., Ying, S., Chi, A. H., Remaley, A. T., Shen, R.-F., et al. (2009) · Blood · doi:10.1182/blood-2008-03-142604 · Cited by 80
Pulmonary Artery Pressure in Lymphangioleiomyomatosis
Taveira‐DaSilva, A. M., Hathaway, O. M., Sachdev, V., Shizukuda, Y., Birdsall, C. W., & Moss, J. (2007) · CHEST Journal · doi:10.1378/chest.07-1205 · Cited by 80
Self-citationGenomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment
Fertrin, K. Y., & Costa, F. F. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.44 · Cited by 80
Hydroxyurea for Children with Sickle Cell Disease
Heeney, M. M., & Ware, R. E. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.11.002 · Cited by 87
Pulmonary arterial hypertension
Raiesdana, A., & Loscalzo, J. (2006) · Annals of Medicine · doi:10.1080/07853890600622143 · Cited by 85
Cardiovascular complications of sickle cell disease
Sachdev, V., Rosing, D. R., & Thein, S. L. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.02.002 · Cited by 92
Self-citationHydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease
Laurin, L., Nachman, P. H., Desai, P. C., Ataga, K. I., & Derebail, V. K. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft295 · Cited by 83
Inhaled whole exhaust and its effect on exercise performance and vascular function
Cutrufello, P. T., Rundell, K. W., Smoliga, J. M., & Stylianides, G. A. (2011) · Inhalation Toxicology · doi:10.3109/08958378.2011.604106 · Cited by 77
Brousseau, D. C., Scott, J. P., Badaki‐Makun, O., Darbari, D. S., Chumpitazi, C. E., Airewele, G. E., Ellison, A. M., Smith‐Whitley, K., Mahajan, P., Sarnaik, S. A., et al. (2015) · Blood · doi:10.1182/blood-2015-05-647107 · Cited by 78
Endothelial function and arterial stiffness in sickle-thalassemia patients
Aessopos, A., Farmakis, D., Tsironi, M., Diamanti-Kandarakis, E., Matzourani, M., Fragodimiri, C., Hatziliami, A., & Karagiorga, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.015 · Cited by 56
Pleiotropic effects of intravascular haemolysis on vascular homeostasis
Kato, G. J., & Taylor, J. G. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08004.x · Cited by 87
Buchanan, I. D., Woodward, M., & Reed, G. W. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20403 · Cited by 75
Pulmonary Hypertension in Hemolytic Disorders
Machado, R. F., & Gladwin, M. T. (2010) · CHEST Journal · doi:10.1378/chest.09-3057 · Cited by 82
Self-citationTransfusion Management in Sickle Cell Disease
Wanko, S. O., & Telen, M. J. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.07.002 · Cited by 75
Little, J. A., McGowan, V., Kato, G. J., Partovi, K. S., Feld, J. J., Marić, I., Martyr, S. E., Taylor, J. G., Machado, R. F., Heller, T., et al. (2006) · PubMed · Cited by 92
Self-citationAlzahrani, M., Damlaj, M., Jeffries, N., Alahmari, B., Singh, A., Rondelli, D., Tisdale, J. F., Saraf, S. L., & Hsieh, M. M. (2021) · British Journal of Haematology · doi:10.1111/bjh.17311 · Cited by 73
Clinical biomarkers in sickle cell disease
Damanhouri, G. A., Jarullah, J. S., Marouf, S., Hindawi, S., Mushtaq, G., & Kamal, M. A. (2014) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.09.005 · Cited by 82
Ashley-Koch, A. E., Elliott, L., Kail, M. E., De Castro, L. M., Jonassaint, J., Jackson, T. L., Price, J., Ataga, K. I., Levesque, M. C., Weinberg, J. B., et al. (2008) · Blood · doi:10.1182/blood-2007-02-074849 · Cited by 73
CURAMA study group, Schnog, J. B., Teerlink, T., van der Dijs, F. P. L., Duits, A. J., & Muskiet, F. A. J. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0983-3 · Cited by 76
Niu, X., Nouraie, M. S., Campbell, A., RANA, S. R., Minniti, C. P., Sable, C., Darbari, D. S., Dham, N., Reading, N. S., Prchal, J. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007956 · Cited by 71
Self-citationAnaesthesia for peculiar cells'a century of sickle cell disease
Firth, P. G. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei129 · Cited by 75
Shenoy, S. (2011) · Hematology · doi:10.1182/asheducation-2011.1.273 · Cited by 72
Detterich, J. A., Kato, R. M., Rábai, M., Meiselman, H. J., Coates, T. D., & Wood, J. C. (2015) · Blood · doi:10.1182/blood-2014-12-614370 · Cited by 71
Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function
Risbano, M. G., Kanias, T., Triulzi, D. J., Donadee, C., Barge, S., Badlam, J. B., Jain, S., Belanger, A., Kim‐Shapiro, D. B., & Gladwin, M. T. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0145oc · Cited by 74
Self-citationBeneficial effects of nitric oxide breathing in adult patients with sickle cell crisis
Head, C. A., Swerdlow, P. S., McDade, W. A., Joshi, R. M., Ikuta, T., Cooper, M. L., & Eckman, J. R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21832 · Cited by 70
Hu, W., Jin, R., Zhang, J., You, T., Peng, Z., Ge, X., Bronson, R. T., Halperin, J. A., Loscalzo, J., & Qin, X. (2010) · Blood · doi:10.1182/blood-2010-01-267112 · Cited by 70
Hydroxyurea for Children with Sickle Cell Disease
Heeney, M. M., & Ware, R. E. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.02.003 · Cited by 81
Factors Associated With Dyspnea in Adult Patients With Sickle Cell Disease
Delclaux, C., Zerah-Lancner, F., Bachir, D., Habibi, A., Monin, J., Godeau, B., & Galacteros, F. (2005) · CHEST Journal · doi:10.1378/chest.128.5.3336 · Cited by 72
Knowledge insufficient: the management of haemoglobin SC disease
Pecker, L. H., Schaefer, B. A., & Luchtman‐Jones, L. (2016) · British Journal of Haematology · doi:10.1111/bjh.14444 · Cited by 77
Ireland, N. P. H. C. O. T. U. A. (2008) · Heart · doi:10.1136/hrt.2007.132118 · Cited by 124
Audard, V., Homs, S., Habibi, A., Galactéros, F., Bartolucci, P., Godeau, B., Renaud, B., Lévy, Y., Grimbert, P., Lang, P., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq083 · Cited by 73
Pulmonary Complications of Hemoglobinopathies
Vij, R., & Machado, R. F. (2010) · CHEST Journal · doi:10.1378/chest.10-0317 · Cited by 74
Guilcher, G. M. T., Truong, T. H., Saraf, S. L., Joseph, J. J., Rondelli, D., & Hsieh, M. M. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.011 · Cited by 73
Sonveaux, P., Lobysheva, I. I., Feron, O., & McMahon, T. J. (2007) · Physiology · doi:10.1152/physiol.00042.2006 · Cited by 69
Morris, C. R., Kim, H.-Y., Trachtenberg, F. L., Wood, J. C., Quinn, C. T., Sweeters, N., Kwiatkowski, J. L., Thompson, A. A., Giardina, P. J., Boudreaux, J. M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-319152 · Cited by 73
Ascorbic acid attenuates endothelial permeability triggered by cell-free hemoglobin
Kuck, J. L., Bastarache, J. A., Shaver, C. M., Fessel, J. P., Dikalov, S., May, J. M., & Ware, L. B. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.058 · Cited by 70
Pulmonary hypertension in thalassemia
Morris, C. R., & Vichinsky, E. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05580.x · Cited by 71
Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
Karimi, M., Musallam, K. M., Cappellini, M. D., Daar, S., El-Beshlawy, A. M., Belhoul, K., Saned, M., Temraz, S. N., Koussa, S., & Taher, A. T. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.05.013 · Cited by 68
Asthma and sickle cell disease: two distinct diseases or part of the same process?
Field, J. J., & DeBaun, M. R. (2009) · Hematology · doi:10.1182/asheducation-2009.1.45 · Cited by 69
Cohen, R. T., Madadi, A. R., Blinder, M. A., DeBaun, M. R., Strunk, R. C., & Field, J. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22098 · Cited by 70
Pulmonary hypertension and NO in sickle cell
Gladwin, M. T., Barst, R. J., Castro, O. L., Gordeuk, V. R., Hillery, C. A., Kato, G. J., Kim-Shapiro, D. B., Machado, R., Morris, C. R., Steinberg, M. H., et al. (2010) · Blood · doi:10.1182/blood-2010-04-282095 · Cited by 65
Self-citationHaematological determinants of cardiac involvement in adults with sickle cell disease
Damy, T., Bodez, D., Habibi, A., Guellich, A., Rappeneau, S., Inamo, J., Guendouz, S., Gellen-Dautremer, J., Pissard, S., Loric, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv555 · Cited by 65
Guidelines for screening, diagnosis and management of hemoglobinopathies
Ghosh, K., Colah, R. B., Choudhry, V., Das, R., Manglani, M. V., Madan, N., Saxena, R., Jain, D., Marwaha, N., Mohanty, D., et al. (2014) · Indian journal of human genetics · doi:10.4103/0971-6866.142841 · Cited by 65
Huynh, T. N., Weigt, S. S., Sugar, C. A., Shapiro, S., & Kleerup, E. C. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.08.006 · Cited by 68
Sickle cell disease in the older adult
Thein, M. S., Igbineweka, N. E., & Thein, S. L. (2016) · Pathology · doi:10.1016/j.pathol.2016.10.002 · Cited by 104
Thalassemia intermedia today: should patients regularly receive transfusions?
Aessopos, A., Kati, M., & Meletis, J. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01192.x · Cited by 72
Fitzhugh, C. D., Hsieh, M. M., Allen, D., Coles, W. A., Seamon, C., Ring, M., Zhao, X., Minniti, C. P., Rodgers, G. P., Schechter, A. N., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141706 · Cited by 64
Self-citationMachado, R. F., Hildesheim, M., Mendelsohn, L., Remaley, A. T., Kato, G. J., & Gladwin, M. T. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08777.x · Cited by 64
Self-citationLiver injury is associated with mortality in sickle cell disease
Feld, J. J., Kato, G. J., Koh, C., Shields, T., Hildesheim, M. E., Kleiner, D. E., Taylor, J. G., Utay, N. S., Douek, D. C., Haynes–Williams, V., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13347 · Cited by 65
Self-citationSodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study
Mack, A. K., McGowan II, V. R., Tremonti, C. K., Ackah, D., Barnett, C., Machado, R. F., Gladwin, M. T., & Kato, G. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07259.x · Cited by 64
Self-citationClinical management of adult sickle-cell disease
Bartolucci, P., & Galactéros, F. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328351c35f · Cited by 69
Liem, R. I., Young, L. T., & Thompson, A. A. (2007) · Haematologica · doi:10.3324/haematol.11576 · Cited by 67
Low forced expiratory volume is associated with earlier death in sickle cell anemia
Kassim, A. A., Payne, A. B., Rodeghier, M., Macklin, E. A., Strunk, R. C., & DeBaun, M. R. (2015) · Blood · doi:10.1182/blood-2015-05-644435 · Cited by 64
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.